Tri-Lo-Mili NDC 71205-746

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-746Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0746Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71205-746-28	71205074628	1 BLISTER PACK in 1 BAG (71205-746-28) / 1 KIT in 1 BLISTER PACKMarketed from Jan 18, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tri-Lo-Mili
Generic name (nonproprietary): norgestimate and ethinyl estradiol
Dosage form: Kit
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205762
Marketing start: Nov 4, 2016
Listing expires: Dec 31, 2026
Identifiers: Product ID 71205-746_5f3dedb9-a500-4e21-8ffa-0d942243c790SPL ID 5f3dedb9-a500-4e21-8ffa-0d942243c790SPL set ID 5f3dedb9-a500-4e21-8ffa-0d942243c790RxCUI 578732, 748797, 749155, 749156, 749157, 1858836UPC 0371205746285

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N471205074628 followed by a unit qualifier and the quantity

Package 71205-0746-28. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Tri-Lo-Mili (norgestimate and ethinyl estradiol tablets) is an estrogen/progestin COC, indicated for use by women to prevent pregnancy. ( 1.1 ) 1.1 Oral Contraception Tri-Lo-Mili (norgestimate and ethinyl estradiol tablets) is indicated for use by females of reproductive potential to prevent pregnancy [see Clinical Studies (14) ] .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205762

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205762
Product	Strength	Form · route	Labeler	Product NDC
Tri-Lo-Milinorgestimate and ethinyl estradiol	—	Kit	Aurobindo Pharma Limited	65862-778
Tri-VyLibra Lonorgestimate and ethinyl estradiol	—	Kit	Afaxys Pharma, LLC	50102-231